Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 68
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02494609 | Oral Contraceptive DDI Study | ||
| NCT06203002 | A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) | ||
| NCT02421510 | Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy | ||
| NCT02531035 | A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone | ||
| NCT02300350 | DDI Study With Multiple-dose LX4211 and Single Dose Digoxin | ||
| NCT01188863 | Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus | ||
| NCT03351478 | Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin | ||
| NCT03285594 | Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents | ||
| NCT01376557 | Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin | ||
| NCT01494233 | A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome | ||
| NCT00847886 | Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis | ||
| NCT06217302 | Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | ||
| NCT03292653 | Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure | ||
| NCT01555008 | Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment | ||
| NCT02926950 | Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin | ||
| NCT06481891 | A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy | ||
| NCT02063659 | Telotristat Etiprate for Carcinoid Syndrome Therapy | ||
| NCT06435156 | Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes | ||
| NCT07211802 | CKM For Safe Use of SGLT2i in Type 1 Diabetes | ||
| NCT01334242 | A Study to Determine the Pharmacodynamics of LX4211 Relative to Meals in Healthy Subjects | ||
| NCT03521934 | Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) | ||
| NCT02926937 | Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy | ||
| NCT02026063 | Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms | ||
| NCT01818232 | Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects | ||
| NCT03242252 | Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control | ||
| NCT02300363 | DDI Study With Multiple-dose LX4211 and Single Dose Rosuvastatin | ||
| NCT00853047 | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy | ||
| NCT01916850 | Study to Determine the Safety, Tolerability and Pharmacokinetics Following Multiple Doses of LX4211 in Healthy Subjects | ||
| NCT02157558 | An Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Fexofenadine in Healthy Subjects | ||
| NCT04455633 | Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain | ||
| NCT01932528 | An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males | ||
| NCT03386344 | Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control | ||
| NCT03302845 | A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects | ||
| NCT02384941 | Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy | ||
| NCT03332771 | Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy | ||
| NCT00962065 | Study of LX4211 in Subjects With Type 2 Diabetes Mellitus | ||
| NCT02373046 | Bioequivalence Study Between 400 mg LX4211 Tablets and 2 X 200 mg LX4211 Tablets | ||
| NCT03242018 | A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control | ||
| NCT02155205 | A Thorough QT Study of Telotristat Etiprate | ||
| NCT03910387 | Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | ||
| NCT02147808 | A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects | ||
| NCT01104415 | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome | ||
| NCT02471274 | PK Study of Sotagliflozin in Subjects With Hepatic Impairment | ||
| NCT01916863 | Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects | ||
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | ||
| NCT06933056 | Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs | ||
| NCT01742208 | Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus | ||
| NCT01417052 | A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis | ||
| NCT01292993 | A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects | ||
| NCT02383940 | Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C |
